The specificity of proteasomes: impact on MHC class I processing and presentation of antigens

被引:63
作者
Niedermann, G [1 ]
Geier, E [1 ]
Lucchiari-Hartz, M [1 ]
Hitziger, N [1 ]
Ramsperger, A [1 ]
Eichmann, K [1 ]
机构
[1] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany
关键词
D O I
10.1111/j.1600-065X.1999.tb01354.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have studied polypeptide processing by purified protea somes, with regard to proteolytic specificity and cytotoxic T-lymphocyte (CTL) epitope generation. Owing to defined preferences with respect to cleavage sites and fragment length, proteasomes degrade polypeptide substrates into cohorts of overlapping oligopeptides. Many of the proteolytic fragments exhibit structural features in common with major histocompatibility complex (MHC) class I ligands including fragment size and frequencies of amino acids at fragment boundaries. Proteasomes frequently generate definitive MHC class I ligands and/or slightly longer peptides, while substantially larger peptides are rare. Individual CTL epitopes are produced in widely varying amounts, often consistent with immunohierarchies among CTL epitopes. We further found that polypeptide processing is remarkably conserved among proteasomes of eukaryotic origin and that invertebrate proteasomes can efficiently produce known high-copy MHC class I ligands, suggesting evolutionary adaptation of the transporter associated with antigen processing and MHC class I to ancient constraints imposed by proteasomal protein degradation.
引用
收藏
页码:29 / 48
页数:20
相关论文
共 98 条
[71]   MCH LIGANDS AND PEPTIDE MOTIFS - FIRST LISTING [J].
RAMMENSEE, HG ;
FRIEDE, T ;
STEVANOVIC, S .
IMMUNOGENETICS, 1995, 41 (04) :178-228
[72]   ON ACTIVE SITE OF PROTEASES .3. MAPPING ACTIVE SITE OF PAPAIN - SPECIFIC PEPTIDE INHIBITORS OF PAPAIN [J].
SCHECHTER, I ;
BERGER, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1968, 32 (05) :898-+
[73]   Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells [J].
Schoenhals, GJ ;
Krishna, RM ;
Grandea, AG ;
Spies, T ;
Peterson, PA ;
Yang, Y ;
Früh, K .
EMBO JOURNAL, 1999, 18 (03) :743-753
[74]   A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome:: A new mechanism for selective inhibition of proteolysis [J].
Sharipo, A ;
Imreh, M ;
Leonchiks, A ;
Imreh, S ;
Masucci, MG .
NATURE MEDICINE, 1998, 4 (08) :939-944
[75]   Contribution of proline residue for efficient production of MHC class I ligands by proteasomes [J].
Shimbara, N ;
Ogawa, K ;
Hidaka, Y ;
Nakajima, H ;
Yamasaki, N ;
Niwa, S ;
Tanahashi, N ;
Tanaka, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23062-23071
[76]   Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region [J].
Shimbara, N ;
Nakajima, H ;
Tanahashi, N ;
Ogawa, K ;
Niwa, S ;
Uenaka, A ;
Nakayama, E ;
Tanaka, K .
GENES TO CELLS, 1997, 2 (12) :785-800
[77]   LMP2(+) PROTEASOMES ARE REQUIRED FOR THE PRESENTATION OF SPECIFIC ANTIGENS TO CYTOTOXIC T-LYMPHOCYTES [J].
SIBILLE, C ;
GOULD, KG ;
WILLARDGALLO, K ;
THOMSON, S ;
RIVETT, AJ ;
POWIS, S ;
BUTCHER, GW ;
DEBAETSELIER, P .
CURRENT BIOLOGY, 1995, 5 (08) :923-930
[78]   TRIMMING OF ANTIGENIC PEPTIDES IN AN EARLY SECRETORY COMPARTMENT [J].
SNYDER, HL ;
YEWDELL, JW ;
BENNINK, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2389-2394
[79]  
Snyder HL, 1998, EUR J IMMUNOL, V28, P1339
[80]  
Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO